Frontiers in Cellular and Infection Microbiology
Scope & Guideline
Pioneering research for a healthier tomorrow.
Introduction
Aims and Scopes
- Infection Biology and Pathogenesis:
Research on the mechanisms of infection by various pathogens, including bacteria, viruses, fungi, and parasites. Studies often focus on understanding how these microorganisms exploit host cellular processes to establish infections. - Host-Microbe Interactions:
Investigations into how the host immune system interacts with pathogens and commensal organisms, including the role of the gut microbiome in health and disease. - Antimicrobial Resistance and Novel Therapeutics:
Research aimed at understanding the mechanisms of antimicrobial resistance and the development of new therapeutic strategies, including the use of phage therapy, probiotics, and novel drug compounds. - Microbial Genomics and Metagenomics:
Utilization of advanced genomic techniques to analyze microbial communities, pathogen genomes, and their implications for disease diagnosis and treatment. - Clinical Microbiology and Diagnostics:
Application of innovative diagnostic tools, including metagenomic next-generation sequencing, to improve pathogen detection and patient outcomes in infectious diseases. - Translational Research:
Focus on bridging laboratory research with clinical applications, including the development of vaccines and therapeutic interventions based on microbiome research.
Trending and Emerging
- Gut Microbiota and Health:
Research focusing on the gut microbiome and its implications for various diseases, including metabolic disorders, autoimmune diseases, and infections, has surged. This reflects a growing recognition of the microbiome's role in overall health. - COVID-19 Research:
There has been an explosive increase in studies related to SARS-CoV-2, encompassing various aspects such as pathogenesis, immune response, diagnostics, and long-term effects, as the pandemic continues to influence global health. - Antimicrobial Resistance Mechanisms:
A growing body of research is dedicated to elucidating the mechanisms behind antimicrobial resistance, including the genetic and phenotypic characteristics of resistant strains, which is crucial for developing new treatment strategies. - Phage Therapy and Novel Antimicrobials:
Interest in bacteriophage therapy and other novel antimicrobial agents has increased as potential alternatives to traditional antibiotics, particularly in the context of rising antimicrobial resistance. - Infection Control and Prevention Strategies:
Studies focusing on innovative infection control measures, including the use of probiotics, dietary interventions, and environmental factors affecting microbial infection rates, are trending.
Declining or Waning
- Traditional Culture-Based Microbiology:
There has been a noticeable decline in publications focusing solely on traditional culture-based methods for microbial identification and susceptibility testing, as newer techniques such as metagenomics gain prominence. - Basic Virology Studies:
Research papers dedicated to basic virology without a clear link to clinical implications or translational applications have become less frequent, as the focus shifts towards understanding viral pathogenesis and therapeutic strategies. - Historical Epidemiological Studies:
There appears to be a reduction in the publication of historical epidemiological studies that do not incorporate modern analytical techniques or tools, as more researchers seek to apply contemporary methods to solve current health issues. - Studies on Non-Pathogenic Microbes:
The exploration of non-pathogenic microbes and their roles in human health has decreased, with more emphasis placed on pathogenic microbes and their interactions with the immune system.
Similar Journals
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
Championing Open Access to Medical Microbiology InsightsWelcome to the International Journal of Medical Microbiology, a leading publication in the field of microbiological research and infectious diseases, offered by Elsevier GmbH. Established in 2000, this esteemed journal provides a scholarly platform for the presentation of high-quality research, reviews, and innovations that bridge medical microbiology and clinical applications. With an impressive impact factor positioning it within the Q1 category across multiple disciplines, including Infectious Diseases, Microbiology, and Medicine, the journal is recognized for its rigorous peer-review process and significant contributions to advancing our understanding of microbial pathogenesis, diagnostics, and therapeutics. The International Journal of Medical Microbiology is committed to open access, promoting the dissemination of knowledge and accessibility for researchers, professionals, and students worldwide. Based in Munich, Germany, the journal continues to play a vital role in the global scientific community, fostering collaborations and inspiring future innovations in the fight against infectious diseases.
FEMS MICROBIOLOGY REVIEWS
Illuminating the Impact of Microbial LifeFEMS Microbiology Reviews, published by Oxford University Press, is a leading journal in the field of microbiology, with a notable impact in related disciplines such as infectious diseases and medicine. Since its inception in 1989, this esteemed journal has grown to occupy a prestigious position, consistently ranking in the first quartile (Q1) in various categories, including Infectious Diseases, Medicine (miscellaneous), and Microbiology. With an impressive Scopus ranking of #13 in Microbiology and #25 in Infectious Diseases, it is recognized for its high-quality and impactful reviews that bridge the gap between fundamental microbiological research and practical applications. Aimed at researchers, professionals, and students alike, FEMS Microbiology Reviews offers critical insights and comprehensive analyses, making it an essential resource for those engaged in the dynamic study of microbial life and its implications for health and disease.
MICROBES AND INFECTION
Elevating Research Standards in Infectious DiseasesMICROBES AND INFECTION is a premier academic journal published by Elsevier, dedicated to the dynamic fields of immunology, infectious diseases, and microbiology. With a notable impact factor reflective of its high-quality research contributions, the journal is categorized in the Q2 quartile across these fields as of 2023. Based in France and operating since 1999, MICROBES AND INFECTION offers a platform for researchers, professionals, and students to disseminate and access cutting-edge findings that drive innovation and knowledge in microbial and infectious disease research. The journal is ranked impressively within the Scopus database, securing ranks such as #16 in Microbiology and #33 in Infectious Diseases, underscoring its high relevance in the scientific community. Subscribers to the journal can expect an array of articles, reviews, and original research, all designed to advance understanding and improve clinical practices in the fight against infectious agents. With its ongoing commitment to open access options, MICROBES AND INFECTION continues to foster global collaboration and information sharing in the pursuit of addressing pressing microbiological challenges.
INFECTION AND IMMUNITY
Connecting Science to Society through Infection and ImmunityINFECTION AND IMMUNITY is a distinguished peer-reviewed journal published by the American Society for Microbiology, focusing on groundbreaking research in the fields of infection, immunology, microbiology, and parasitology. Established in 1971, this journal has built a robust legacy, converging years of scientific discovery with a vision towards 2024 and beyond. With an impressive Impact Factor, the journal holds significant rankings in various categories; its Q1 status in both Infectious Diseases and Parasitology underscores its high relevance and quality within the scientific community. Researchers and professionals alike will benefit from its content, as it promotes the latest advances in understanding immune responses and infectious agents, further legitimizing its place among the top quartiles of its respective fields. Access options are provided through traditional subscription models, ensuring a broad charitable dissemination of knowledge. As a pivotal resource for scholars and practitioners alike, INFECTION AND IMMUNITY stands at the forefront of microbiological and immunological research, fostering essential discourse that is crucial for advancing public health and scientific insight.
Annals of Clinical Microbiology and Antimicrobials
Uniting global voices in the battle against infections.Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.
CLINICAL MICROBIOLOGY AND INFECTION
Transforming Knowledge into Clinical PracticeCLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.
Journal of Pathogens
Innovating Solutions in Microbiology and Disease ControlJournal of Pathogens is a premier peer-reviewed journal published by HINDAWI LTD, focusing on the critical field of microbiology, infectious diseases, and the mechanisms of pathogen interactions with hosts. Since its inception in 2011 as an Open Access journal, it has aimed to provide a platform for high-quality research articles, reviews, and case studies that enhance our understanding of pathogenesis and advance the science of disease control. With its commitment to making research freely accessible, the journal attracts a global audience of researchers, professionals, and graduate students keen on exploring innovative findings and applications in the study of pathogens. While the journal does not currently have an established H-index or category quartiles, its relevance and importance in the field continue to grow as it seeks to bridge knowledge gaps and facilitate impactful discussions in infectious disease research. Located at Adam House, 3rd Floor, 1 Fitzroy Square, London W1T 5HF, England, the Journal of Pathogens invites submissions that contribute to the ever-evolving landscape of pathogen research and public health.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS
Illuminating the Pathways of Microbial Life and Molecular MechanismsMICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, published by the American Society for Microbiology, is a premier journal dedicated to advancing the fields of microbiology and molecular biology. With an impressive impact factor reflective of its Q1 ranking in categories such as Immunology, Infectious Diseases, and Molecular Biology, this journal consistently showcases high-quality, peer-reviewed articles that contribute to the current understanding of microbial life and molecular mechanisms. Operating since 1997, the journal aims to bridge the gap between microbiological methods and molecular biology applications, making it an essential resource for researchers, professionals, and students alike. Readers can access content through various platforms, ensuring that the latest findings are readily available to the scientific community. With its esteemed reputation, MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS remains a leading voice in the exploration of the life sciences, catering to a broad audience deeply invested in unraveling the complexities of microbial and molecular systems.
TRENDS IN MICROBIOLOGY
Advancing the Frontiers of Microbial ScienceTRENDS IN MICROBIOLOGY is a premier academic journal published by CELL PRESS, renowned for its high-impact research contributions in the fields of microbiology, infectious diseases, medical microbiology, and virology. With an impressive impact factor and a notable Scopus ranking—placing it in the top tiers of its categories, including a remarkable Q1 status in multiple disciplines—this journal is essential for researchers, professionals, and students aiming to stay at the forefront of innovative microbial research and ongoing advancements in pathogen biology. Since its inception in 1993, TRENDS IN MICROBIOLOGY has provided a platform for thought-provoking reviews and critical insights, fostering discussions that shape the future of the microbiological sciences. Based in the United Kingdom, TRENDS IN MICROBIOLOGY continues to lead the way in disseminating vital knowledge within the global scientific community.
Indian Journal of Medical Microbiology
Pioneering Research in Medical Microbiology Since 1986Indian Journal of Medical Microbiology, published by Elsevier, is a pivotal peer-reviewed journal dedicated to the field of medical microbiology, providing a vital platform for research and scholarship since its inception in 1986. With an Open Access model established in 2001, it ensures the dissemination of scientific knowledge to a global audience, enhancing accessibility for researchers, professionals, and students alike. The journal's scope spans critical areas including immunology, infectious diseases, and microbiology, with an impressive trajectory marked by converged years of publication allowing for a comprehensive exploration of evolving scientific trends. As of 2023, the journal holds a Q3 ranking in Infectious Diseases and Microbiology (medical) and a Q4 ranking in Immunology and Microbiology categories, reflecting its significant yet growing impact in the field. Researchers seeking to contribute to or stay updated on the latest advancements in medical microbiology will find the Indian Journal of Medical Microbiology a valuable resource, as it consistently bridges the gap between emerging science and clinical application.